Global and China Urological Cancer Therapeutics Drugs Market Insights, Forecast to 2026

Global and China Urological Cancer Therapeutics Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Urological Cancer Therapeutics Drugs Product Introduction
1.2 Market Segments
1.3 Key Urological Cancer Therapeutics Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Type
1.4.2 Xofigo (radium Ra 223 dichloride)
1.4.3 Jevtana (cabazitaxel)
1.4.4 Inlyta (axitinib)
1.4.5 Votrient (pazopanib hydrochloride)
1.4.6 Sutent (sunitinib malate)
1.4.7 Zytiga (abiraterone acetate)
1.4.8 Xtandi (enzalutamide)
1.4.9 Opdivo (nivolumab)
1.4.10 Provenge (sipuleucel-T)
1.5 Market by Application
1.5.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Research Laboratory
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Urological Cancer Therapeutics Drugs Market Size, Estimates and Forecasts
2.1.1 Global Urological Cancer Therapeutics Drugs Revenue 2015-2026
2.1.2 Global Urological Cancer Therapeutics Drugs Sales 2015-2026
2.2 Global Urological Cancer Therapeutics Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Urological Cancer Therapeutics Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Urological Cancer Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Urological Cancer Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Urological Cancer Therapeutics Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Region (2021-2026)
3 Global Urological Cancer Therapeutics Drugs Competitor Landscape by Players
3.1 Global Top Urological Cancer Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Urological Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Urological Cancer Therapeutics Drugs Manufacturers by Revenue
3.2.1 Global Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Urological Cancer Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Urological Cancer Therapeutics Drugs Revenue in 2019
3.2.5 Global Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Urological Cancer Therapeutics Drugs Price by Manufacturers
3.4 Global Urological Cancer Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Urological Cancer Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Urological Cancer Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Urological Cancer Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Urological Cancer Therapeutics Drugs Market Size by Type (2015-2020)
4.1.1 Global Urological Cancer Therapeutics Drugs Sales by Type (2015-2020)
4.1.2 Global Urological Cancer Therapeutics Drugs Revenue by Type (2015-2020)
4.1.3 Urological Cancer Therapeutics Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Urological Cancer Therapeutics Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Urological Cancer Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Urological Cancer Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Urological Cancer Therapeutics Drugs Market Size by Application (2015-2020)
5.1.1 Global Urological Cancer Therapeutics Drugs Sales by Application (2015-2020)
5.1.2 Global Urological Cancer Therapeutics Drugs Revenue by Application (2015-2020)
5.1.3 Urological Cancer Therapeutics Drugs Price by Application (2015-2020)
5.2 Urological Cancer Therapeutics Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Urological Cancer Therapeutics Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Urological Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
6.1.1 China Urological Cancer Therapeutics Drugs Sales YoY Growth 2015-2026
6.1.2 China Urological Cancer Therapeutics Drugs Revenue YoY Growth 2015-2026
6.1.3 China Urological Cancer Therapeutics Drugs Market Share in Global Market 2015-2026
6.2 China Urological Cancer Therapeutics Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Urological Cancer Therapeutics Drugs Players by Sales (2015-2020)
6.2.2 China Top Urological Cancer Therapeutics Drugs Players by Revenue (2015-2020)
6.3 China Urological Cancer Therapeutics Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Urological Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Urological Cancer Therapeutics Drugs Price by Type (2015-2020)
6.4 China Urological Cancer Therapeutics Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Urological Cancer Therapeutics Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Urological Cancer Therapeutics Drugs Price Forecast by Type (2021-2026)
6.5 China Urological Cancer Therapeutics Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Urological Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Urological Cancer Therapeutics Drugs Price by Application (2015-2020)
6.6 China Urological Cancer Therapeutics Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Urological Cancer Therapeutics Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Urological Cancer Therapeutics Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Urological Cancer Therapeutics Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Urological Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
7.2 North America Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
7.2.1 North America Urological Cancer Therapeutics Drugs Sales by Country (2015-2020)
7.2.2 North America Urological Cancer Therapeutics Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Urological Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
8.2 Europe Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
8.2.1 Europe Urological Cancer Therapeutics Drugs Sales by Country
8.2.2 Europe Urological Cancer Therapeutics Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Urological Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Urological Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
10.2.1 Latin America Urological Cancer Therapeutics Drugs Sales by Country
10.2.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country
11.2.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Urological Cancer Therapeutics Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Urological Cancer Therapeutics Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Description and Business Overview
12.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Astellas
12.5.1 Astellas Corporation Information
12.5.2 Astellas Description and Business Overview
12.5.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Astellas Urological Cancer Therapeutics Drugs Products Offered
12.5.5 Astellas Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Corporation Information
12.7.2 Abbott Laboratories Description and Business Overview
12.7.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Products Offered
12.7.5 Abbott Laboratories Recent Development
12.8 Celgene Corporation
12.8.1 Celgene Corporation Corporation Information
12.8.2 Celgene Corporation Description and Business Overview
12.8.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Products Offered
12.8.5 Celgene Corporation Recent Development
12.9 Dendreon Corporation
12.9.1 Dendreon Corporation Corporation Information
12.9.2 Dendreon Corporation Description and Business Overview
12.9.3 Dendreon Corporation Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Products Offered
12.9.5 Dendreon Corporation Recent Development
12.10 Ferring Pharmaceuticals
12.10.1 Ferring Pharmaceuticals Corporation Information
12.10.2 Ferring Pharmaceuticals Description and Business Overview
12.10.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Products Offered
12.10.5 Ferring Pharmaceuticals Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Urological Cancer Therapeutics Drugs Products Offered
12.11.5 Novartis Recent Development
12.12 Indevus Pharmaceuticals Inc
12.12.1 Indevus Pharmaceuticals Inc Corporation Information
12.12.2 Indevus Pharmaceuticals Inc Description and Business Overview
12.12.3 Indevus Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Indevus Pharmaceuticals Inc Products Offered
12.12.5 Indevus Pharmaceuticals Inc Recent Development
12.13 Ipsen
12.13.1 Ipsen Corporation Information
12.13.2 Ipsen Description and Business Overview
12.13.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Ipsen Products Offered
12.13.5 Ipsen Recent Development
12.14 Roche Healthcare
12.14.1 Roche Healthcare Corporation Information
12.14.2 Roche Healthcare Description and Business Overview
12.14.3 Roche Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Roche Healthcare Products Offered
12.14.5 Roche Healthcare Recent Development
12.15 Sanofi S.A.
12.15.1 Sanofi S.A. Corporation Information
12.15.2 Sanofi S.A. Description and Business Overview
12.15.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Sanofi S.A. Products Offered
12.15.5 Sanofi S.A. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Urological Cancer Therapeutics Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Urological Cancer Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Urological Cancer Therapeutics Drugs Market Segments
Table 2. Ranking of Global Top Urological Cancer Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Xofigo (radium Ra 223 dichloride)
Table 5. Major Manufacturers of Jevtana (cabazitaxel)
Table 6. Major Manufacturers of Inlyta (axitinib)
Table 7. Major Manufacturers of Votrient (pazopanib hydrochloride)
Table 8. Major Manufacturers of Sutent (sunitinib malate)
Table 9. Major Manufacturers of Zytiga (abiraterone acetate)
Table 10. Major Manufacturers of Xtandi (enzalutamide)
Table 11. Major Manufacturers of Opdivo (nivolumab)
Table 12. Major Manufacturers of Provenge (sipuleucel-T)
Table 13. Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Urological Cancer Therapeutics Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Urological Cancer Therapeutics Drugs Sales by Regions 2015-2020 (K MT)
Table 16. Global Urological Cancer Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Urological Cancer Therapeutics Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Urological Cancer Therapeutics Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 19. Global Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Urological Cancer Therapeutics Drugs Sales Share by Manufacturers (2015-2020)
Table 21. Global Urological Cancer Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Urological Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urological Cancer Therapeutics Drugs as of 2019)
Table 23. Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Urological Cancer Therapeutics Drugs Price (2015-2020) (USD/MT)
Table 26. Urological Cancer Therapeutics Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Urological Cancer Therapeutics Drugs Product Type
Table 28. Date of International Manufacturers Enter into Urological Cancer Therapeutics Drugs Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Urological Cancer Therapeutics Drugs Sales by Type (2015-2020) (K MT)
Table 31. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2015-2020)
Table 32. Global Urological Cancer Therapeutics Drugs Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 34. Urological Cancer Therapeutics Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2021-2026)
Table 36. Global Urological Cancer Therapeutics Drugs Sales by Application (2015-2020) (K MT)
Table 37. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2015-2020)
Table 38. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2021-2026)
Table 39. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Application (2021-2026)
Table 40. Global Urological Cancer Therapeutics Drugs Revenue by Application (2015-2020) (US$ Million)
Table 41. Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 42. China Urological Cancer Therapeutics Drugs Sales (K MT) of Key Companies (2015-2020)
Table 43. China Urological Cancer Therapeutics Drugs Sales Share by Company (2015-2020)
Table 44. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) by Company (2015-2020)
Table 45. China Urological Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 46. China Urological Cancer Therapeutics Drugs Sales Share by Type (2015-2020)
Table 47. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 48. China Urological Cancer Therapeutics Drugs Price (K MT) by Type (2015-2020)
Table 49. China Urological Cancer Therapeutics Drugs Sales (K MT) by Type (2021-2026)
Table 50. China Urological Cancer Therapeutics Drugs Sales Share by Type (2021-2026)
Table 51. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 52. China Urological Cancer Therapeutics Drugs Revenue Share by Type (2021-2026)
Table 53. China Urological Cancer Therapeutics Drugs Price (K MT) by Type (2021-2026)
Table 54. China Urological Cancer Therapeutics Drugs Sales (K MT) by Application (2015-2020)
Table 55. China Urological Cancer Therapeutics Drugs Sales Share by Application (2015-2020)
Table 56. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 57. China Urological Cancer Therapeutics Drugs Sales (K MT) by Application (2021-2026)
Table 58. China Urological Cancer Therapeutics Drugs Sales Share by Application (2021-2026)
Table 59. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 60. China Urological Cancer Therapeutics Drugs Revenue Share by Application (2021-2026)
Table 61. North America Urological Cancer Therapeutics Drugs Sales by Country (2015-2020) (K MT)
Table 62. North America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 63. North America Urological Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 65. Europe Urological Cancer Therapeutics Drugs Sales by Country (2015-2020) (K MT)
Table 66. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 67. Europe Urological Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 69. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2015-2020) (K MT)
Table 70. Asia Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 71. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2015-2020) (US$ Million)
Table 72. Asia Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 73. Latin America Urological Cancer Therapeutics Drugs Sales by Country (2015-2020) (K MT)
Table 74. Latin America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 75. Latin Americaa Urological Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 76. Latin America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 77. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2015-2020) (K MT)
Table 78. Middle East and Africa Urological Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 79. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 80. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Business Overview
Table 83. Novartis Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Novartis Urological Cancer Therapeutics Drugs Product
Table 85. Novartis Recent Development
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Business Overview
Table 88. Pfizer Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Pfizer Product
Table 90. Pfizer Recent Development
Table 91. Johnson & Johnson Corporation Information
Table 92. Johnson & Johnson Description and Business Overview
Table 93. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Johnson & Johnson Product
Table 95. Johnson & Johnson Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Business Overview
Table 98. AstraZeneca Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Astellas Corporation Information
Table 102. Astellas Description and Business Overview
Table 103. Astellas Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Astellas Product
Table 105. Astellas Recent Development
Table 106. Bristol-Myers Squibb Corporation Information
Table 107. Bristol-Myers Squibb Description and Business Overview
Table 108. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Bristol-Myers Squibb Product
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Abbott Laboratories Corporation Information
Table 112. Abbott Laboratories Description and Business Overview
Table 113. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Abbott Laboratories Product
Table 115. Abbott Laboratories Recent Development
Table 116. Celgene Corporation Corporation Information
Table 117. Celgene Corporation Description and Business Overview
Table 118. Celgene Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Celgene Corporation Product
Table 120. Celgene Corporation Recent Development
Table 121. Dendreon Corporation Corporation Information
Table 122. Dendreon Corporation Description and Business Overview
Table 123. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Dendreon Corporation Product
Table 125. Dendreon Corporation Recent Development
Table 126. Ferring Pharmaceuticals Corporation Information
Table 127. Ferring Pharmaceuticals Description and Business Overview
Table 128. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Ferring Pharmaceuticals Product
Table 130. Ferring Pharmaceuticals Recent Development
Table 131. GlaxoSmithKline plc Corporation Information
Table 132. GlaxoSmithKline plc Description and Business Overview
Table 133. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. GlaxoSmithKline plc Product
Table 135. GlaxoSmithKline plc Recent Development
Table 136. Indevus Pharmaceuticals Inc Corporation Information
Table 137. Indevus Pharmaceuticals Inc Description and Business Overview
Table 138. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Indevus Pharmaceuticals Inc Product
Table 140. Indevus Pharmaceuticals Inc Recent Development
Table 141. Ipsen Corporation Information
Table 142. Ipsen Description and Business Overview
Table 143. Ipsen Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Ipsen Product
Table 145. Ipsen Recent Development
Table 146. Roche Healthcare Corporation Information
Table 147. Roche Healthcare Description and Business Overview
Table 148. Roche Healthcare Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Roche Healthcare Product
Table 150. Roche Healthcare Recent Development
Table 151. Sanofi S.A. Corporation Information
Table 152. Sanofi S.A. Description and Business Overview
Table 153. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 154. Sanofi S.A. Product
Table 155. Sanofi S.A. Recent Development
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key Urological Cancer Therapeutics Drugs Players
Table 160. Urological Cancer Therapeutics Drugs Customers List
Table 161. Urological Cancer Therapeutics Drugs Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Urological Cancer Therapeutics Drugs Product Picture
Figure 2. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Xofigo (radium Ra 223 dichloride) Product Picture
Figure 4. Jevtana (cabazitaxel) Product Picture
Figure 5. Inlyta (axitinib) Product Picture
Figure 6. Votrient (pazopanib hydrochloride) Product Picture
Figure 7. Sutent (sunitinib malate) Product Picture
Figure 8. Zytiga (abiraterone acetate) Product Picture
Figure 9. Xtandi (enzalutamide) Product Picture
Figure 10. Opdivo (nivolumab) Product Picture
Figure 11. Provenge (sipuleucel-T) Product Picture
Figure 12. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020 & 2026
Figure 13. Hospital
Figure 14. Medical Research Laboratory
Figure 15. Others
Figure 16. Urological Cancer Therapeutics Drugs Report Years Considered
Figure 17. Global Urological Cancer Therapeutics Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Urological Cancer Therapeutics Drugs Sales 2015-2026 (K MT)
Figure 19. Global Urological Cancer Therapeutics Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region in 2019
Figure 22. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 24. Global Urological Cancer Therapeutics Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Urological Cancer Therapeutics Drugs Revenue in 2019
Figure 26. Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 29. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type in 2019
Figure 31. Global Urological Cancer Therapeutics Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2019
Figure 34. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application in 2019
Figure 36. China Urological Cancer Therapeutics Drugs Sales Growth Rate 2015-2026 (K MT)
Figure 37. China Urological Cancer Therapeutics Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 38. China Urological Cancer Therapeutics Drugs Market Share in Global Market 2015-2026
Figure 39. China 5 and 10 Largest Urological Cancer Therapeutics Drugs Players Market Share by Revenue in Urological Cancer Therapeutics Drugs in 2019
Figure 40. China Urological Cancer Therapeutics Drugs Revenue Share by Type (2015-2020)
Figure 41. China Urological Cancer Therapeutics Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 42. China Urological Cancer Therapeutics Drugs Revenue Share by Application (2015-2020)
Figure 43. China Urological Cancer Therapeutics Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 44. North America Urological Cancer Therapeutics Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 45. North America Urological Cancer Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. North America Urological Cancer Therapeutics Drugs Sales Market Share by Country in 2019
Figure 47. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 48. U.S. Urological Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.S. Urological Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Canada Urological Cancer Therapeutics Dru

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs